Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 6-7, Juin–Juillet 2012
Page(s) 618 - 624
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012286015
Publié en ligne 16 juillet 2012
  1. O’Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 2010 ; 11 : 171–181. [CrossRef] [PubMed]
  2. Shay JW, Wright WE. Telomeres and telomerase in normal and cancer stem cells. FEBS Lett 2010 ; 584 : 3819–3825. [CrossRef] [PubMed]
  3. Londoño-Vallejo A, Lenain C, Gilson E. Cibler les télomères pour forcer les cellules cancéreuses à rentrer en sénescence. Med Sci (Paris) 2008 ; 24 : 383–389. [CrossRef] [EDP Sciences] [PubMed]
  4. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998 ; 279 : 349–352. [CrossRef] [PubMed]
  5. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997 ; 33 : 787–791. [CrossRef] [PubMed]
  6. De Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005 ; 19 : 2100–2110. [CrossRef] [PubMed]
  7. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000 ; 110 : 768–779. [CrossRef] [PubMed]
  8. Hoareau-Aveilla C, Henry Y, Leblanc T. La dyskératose congénitale : une maladie méconnue due à un maintien défectueux des télomères. Med Sci (Paris) 2008 ; 24 : 390–398. [CrossRef] [EDP Sciences] [PubMed]
  9. Hreidarsson S, Kristjansson K, Johannesson G, et al. A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr Scand 1988 ; 77 : 773–775. [CrossRef] [PubMed]
  10. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999 ; 402 : 551–555. [CrossRef] [PubMed]
  11. Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998 ; 19 : 32–38. [CrossRef] [PubMed]
  12. Rashid R, Liang B, Baker DL, et al. Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita. Mol Cell 2006 ; 21 : 249–260. [CrossRef] [PubMed]
  13. Zeng XL, Thumati NR, Fleisig HB, et al. The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. Hum Mol Genet 2011 ; 21 : 721–729. [CrossRef] [PubMed]
  14. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001 ; 413 : 432–435. [CrossRef] [PubMed]
  15. Ly H, Calado RT, Allard P, et al. Functional characterization of telomerase RNA variants found in patients with hematologic disorders. Blood 2005 ; 105 : 2332–2339. [CrossRef] [PubMed]
  16. Du HY, Idol R, Robledo S, et al. Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p-syndrome. Aging Cell 2007 ; 6 : 689–697. [CrossRef] [PubMed]
  17. Savage SA, Giri N, Baerlocher GM, et al. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet 2008 ; 82 : 501–509. [CrossRef] [PubMed]
  18. Canudas S, Houghtaling BR, Bhanot M, et al. A role for heterochromatin protein 1γ at human telomeres. Genes Dev 2011 ; 25 : 1807–1819. [CrossRef] [PubMed]
  19. Yang D, He Q, Kim H, et al. TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase. J Biol Chem 2011 ; 286 : 23022–23030. [CrossRef] [PubMed]
  20. Walne AJ, Vulliamy T, Marrone A, et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet 2007 ; 16 : 1619–1629. [CrossRef] [PubMed]
  21. Vulliamy T, Beswick R, Kirwan M, et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci USA 2008 ; 105 : 8073–8078. [CrossRef]
  22. Zhong F, Savage SA, Shkreli M, et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev 2011 ; 25 : 11–16. [CrossRef] [PubMed]
  23. Walne AJ, Vulliamy T, Beswick R, et al. Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome. Hum Mol Genet 2010 ; 19 : 4453–4461. [CrossRef] [PubMed]
  24. Du HY, Pumbo E, Ivanovich J, et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 2009 ; 113 : 309–316. [CrossRef] [PubMed]
  25. Aviv A, Hunt SC, Lin J, et al. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots, qPCR. Nucleic Acids Res 2011 ; 39 : e134. [CrossRef] [PubMed]
  26. Alter BP, Baerlocher GM, Savage SA, et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007 ; 110 : 1439–1447. [CrossRef] [PubMed]
  27. Vulliamy T, Marrone A, Szydlo R, et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 2004 ; 36 : 447–449. [CrossRef] [PubMed]
  28. Vulliamy TJ, Kirwan MJ, Beswick R, et al. Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations. PLoS One 2011 ; 6 : e24383. [CrossRef] [PubMed]
  29. Alter BP, Rosenberg PS, Giri N, et al. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica 2011 ; 97 : 353–359. [CrossRef] [PubMed]
  30. Touzot F, Gaillard L, Vasquez N, et al. Heterogeneous telomere defects in patients with severe forms of dyskeratosis congenita. J Allergy Clin Immunol 2011 ; 129 : 473–482. [CrossRef] [PubMed]
  31. Revy P, Busslinger M, Tashiro K, et al. A syndrome involving intrauterine growth retardation, microcephaly, cerebellar hypoplasia, B lymphocyte deficiency, progressive pancytopenia. Pediatrics 2000 ; 105 : E39. [CrossRef] [PubMed]
  32. Touzot F, Callebaut I, Soulier J, et al. Function of Apollo (SNM1B) at telomere highlighted by a splice variant identified in a patient with Hoyeraal-Hreidarsson syndrome. Proc Natl Acad Sci USA 2010 ; 107 : 10097–10102. [CrossRef]
  33. Ye J, Lenain C, Bauwens S, et al. TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell 2010 ; 142 : 230–242. [CrossRef] [PubMed]
  34. Demuth I, Digweed M, Concannon P. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation. Oncogene 2004 ; 23 : 8611–8618. [CrossRef] [PubMed]
  35. Zinsser F. Atrophia cutis reticularis cum pigtnentatione, dystrophia unguim et leukuplakia oris. Ikonographia Dermatol (Hyoto) 1910 ; 5 : 219–223.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.